Types of ACO Participants, or Combinations of Participants, That Formed the ACO

The Greater Baltimore Health Alliance (GBHA) is a wholly owned Limited Liability Company (LLC) of GBMC Healthcare, Inc. It was created to align health care providers and achieve a three part aim of Improved Health, Improved Care and Less Waste. GBHA has successfully brought over 90 primary care providers together to participate in the Medicare Shared Savings Program. GBHA includes providers from 5 independent practices, Greater Baltimore Medical Associates (GBMA), and Greater Baltimore Geriatric and Palliative Medicine. The Greater Baltimore Health Alliance is one of only 433 Accountable Care Organizations (ACOs) in the nation, participating in the Medicare Shared Savings Program. It is one of eleven operating in the State of Maryland and the first ACO in Maryland associated with a hospital.

ACO Name and Location:

Greater Baltimore Health Alliance
6545 N. Charles Street
S. Chapman Bldg, Suite 102
Towson, MD 21204

ACO Primary Contact:

Mary Ely
Executive Director
Greater Baltimore Health Alliance
mely@gbmc.org
Phone: (443) 849-2435
Fax: (443) 849-3138

Organizational Information:

ACO Participants

Chapel View Family Care GBMC at Texas Station Greater Baltimore Medical Associates
Feirtag & Ramos, P.A. GBMC Family Care Associates Greater Baltimore Medical Center (Hospital)
GBMC at Perry Hall GBMC Geriatrics GBMC Jarrettsville Family Care
GBMC at Hunt Manor GBMC Hospice & Palliative Medicine Joseph T. Pallan, M.D., P.A.
GBMC at Hunt Valley GBMC Medicine for Adults Josephs, Turner, and O'Malley, M.D., P.A.
GBMC at Owings Mills GBMC Primary Care Physicians Vincent P. Wroblewski, M.D.

ACO Participants in Joint Ventures Between ACO Professionals and Hospitals:

No participants are involved in a joint venture between ACO professionals and hospitals.

ACO Governing Body

GBHA Board of Directors

W. Anthony Riley, M.D. ACO Participant Chair & Voting Member Geriatrics Greater Baltimore Medical Associates
Fred Chan, MD ACO Participant Voting Member Chief Medical Information Officer Greater Baltimore Medical Associates
Bradford Ebright, M.D. ACO Participant Voting Member Family Medicine Chapel View Family Care
Robin Motter-Mast, D.O. ACO Participant Voting Member Family Medicine Greater Baltimore Medical Associates
Debbie Jones-Shook, C.R.N.P. ACO Participant Voting Member Family Medicine Greater Baltimore Medical Associates
Linda Walsh, M.D. ACO Participant Voting Member Family Medicine GBMC Jarrettsville Family Care
Ronald Stringer Medicare Beneficiary Voting Member - -
John Chessare, M.D. Hospital Administrator Voting Member Chief Executive Officer GBMC Healthcare, Inc.
Harold Tucker, M.D. Hospital Administrator Non-voting Member President, GBMA Greater Baltimore Medical Associates

 

Key ACO Clinical and Administrative Leadership

Mary Ely Executive Director, GBHA
Mark Lamos, M.D. Medical Director, GBHA
Lisa Wojeski Compliance Official
Megan Priolo Quality Assurance/Improvement

 

ACO Committees and Key Leadership

GBHA Specialty Advisory Committee

Harold Tucker, M.D. Chair & Voting Member Greater Baltimore Medical Associates GBMC Medical Community
Ruth Horowitz, M.D. Voting Member Bay West Endocrinology GBMC Medical Community
Francis Rotolo, M.D. Voting Member Finney & Trimble Associates GBMC Medical Community
Lee M. Schmidt, M.D. Voting Member Orthopaedic Specialists of Maryland GBMC Medical Community
Joseph Russo, D.P.M. Voting Member Podiatry Associates, PA GBMC Medical Community
James Porterfield, M.D. Voting Member Johns Hopkins Cardiology GBMC Medical Community
Fred Chan, M.D. Voting Member Chief Medical Information Officer, GBMC GBMC Medical Community
Paul Celano, M.D. Voting Member GBMC Berman Cancer Institute GBMC Medical Community
John Thompson, M.D. Voting Member Retina Specialists of Maryland GBMC Medical Community
Ronald Tutrone, M.D. Voting Member Chesapeake Urology GBMC Medical Community
John Chessare, M.D. Non-voting Member CEO GBMC healthcare, Inc. GBMC Medical Community
Mark Lamos, M.D. Non-voting Member GBHA Medical Director ACO Participant

 

GBHA Quality Committee

W. Anthony Riley, M.D. Chair & Voting Member ACO Participant
Debbie Jones-Shook, C.R.N.P. Voting Member ACO Participant
Harold Tucker, M.D. Voting Member GBMC Medical Community
John Chessare, M.D. Non-voting Member Hospital Administrator
Mark Lamos, M.D. Non-voting Member Medical Director and ACO Participant
Robert Turner, M.D. Voting Member ACO Participant

 

Amount of Shared Savings & Losses

Agreement period beginning 2012, Performance Year 1: $0

Agreement period beginning 2012, Performance Year 2014: $0

Agreement period beginning 2012, Performance Year 2015: $0

Shared Savings Distribution

Agreement period beginning 2012, Performance Year 1: $0

Agreement period beginning 2012, Performance Year 2014: $0

Agreement period beginning 2012, Performance Year 2015: -$2,405,021

Payment Rule Waivers

GBHA does not use the SNF 3-Day Rule Waiver. We are a Track 1 ACO.

 

Quality Performance

Measure number Measure Name 2015 reporting period
ACO Performance Rate Mean Performance Rate
(MSSP ACOs)
ACO - 1 CAHPS: Getting Timely Care, Appointments, and Information 84.74 80.61
ACO - 2 CAHPS: How Well Your Providers Communicate 94.86 92.65
ACO - 3 CAHPS: Patients’ Rating of Provider 93.87 91.94
ACO - 4 CAHPS: Access to Specialists 84.01 83.61
ACO - 5 CAHPS: Health Promotion and Education 60.22 59.06
ACO - 6 CAHPS: Shared Decision Making 74.62 75.17
ACO - 7 CAHPS: Health Status/Functional Status 72.20 72.30
ACO - 34 CAHPS: Stewardship of Patient Resources* 28.94 26.87
ACO - 8 Risk Standardized, All Condition Readmission 14.66 14.86
ACO - 35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)* 17.58 18.07
ACO - 36 All-Cause Unplanned Admissions for Patients with Diabetes* 55.27 54.60
ACO - 37 All-Cause Unplanned Admissions for Patients with Heart Failure* 74.72 76.96
ACO - 38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 65.85 62.92
ACO - 9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.14 1.11
ACO - 10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.32 1.04
ACO - 11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 95.40% 76.22%
ACO - 39 Documentation of Current Medications in the Medical Record* 77.69% 84.07%
ACO - 13 Falls: Screening for Future Fall Risk 68.93% 56.46%
ACO - 14 Preventive Care and Screening: Influenza Immunization 64.87% 62.03%
ACO - 15 Pneumonia Vaccination Status for Older Adults 66.72% 63.73%
ACO - 16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 67.38% 71.15%
ACO - 17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 88.91% 90.16%
ACO - 18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 46.52% 45.25%
ACO - 19 Colorectal Cancer Screening 65.84% 60.06%
ACO - 20 Breast Cancer Screening 67.44% 65.67%
ACO - 21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 49.59% 70.04%
ACO - 40 Depression Remission at Twelve Months* N/A N/A
ACO - 27 Diabetes Mellitus: Hemoglobin A1c Poor Control 16.98% 20.38%
ACO - 41 Diabetes: Eye Exam* 34.66% 41.05%
ACO - 28 Hypertension: Controlling High Blood Pressure 74.81% 69.62%
ACO - 30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 87.18% 83.82%
ACO - 31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 88.00% 87.22%
ACO - 33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 80.21% 77.73%

Reporting Period 2012 Through 2014

Measure number Performance measure 2012 reporting period 2013 reporting period 2014 reporting period
ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for all ACOs ACO performance rate Mean performance rate for all ACOs
ACO #1 Getting Timely Care, Appointments, and Information - - - - 84.29 80.13
ACO #2 How Well Your Doctors Communicate - - - - 94.06 92.39
ACO #3 Patients' Rating of Doctor - - - - 92.73 91.58
ACO #4 Access to Specialists - - - - 83.08 83.97
ACO #5 Health Promotion and Education - - - - 61.76 58.29
ACO #6 Shared Decision Making - - - - 74.35 74.6
ACO #7 Health Status/Functional Status - - - - 73.17 71.1
ACO #8 Risk Standardized, All Condition Readmissions 15.01 15.42 14 14.9 14.71 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults 0.7 1.13 0.89 1.17 0.92 1.08
ACO #10 ASC Admission: Heart Failure 1.25 1.09 1.35 1.2 1.38 1.19
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment 75 59.87 67.14 66.21 77.27 76.71
ACO #12 Medication Reconciliation - - - - 82.24 83.55
ACO #13 Falls: Screening for Fall Risk - - - - 54.98 45.67
ACO #14 Influenza Immunization - - - - 65.32 57.74
ACO #15 Pneumococcal Vaccination  - - - - 55.15 55.22
ACO #16 Adult Weight Screening and Follow-up - - - - 53.12 67.01
ACO #17 Tobacco Use Assessment and Cessation Intervention - - - - 90.08 87.04
ACO #18 Depression Screening - - - - 53.08 39.37
ACO #19 Colorectal Cancer Screening - - - - 55.32 56.16
ACO #20 Mammography Screening - - - - 65.67 61.42
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years - - - - 51.36 60.36
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) - N/A - N/A 63.22 N/A
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) - N/A - N/A N/A N/A
ACO #24 Blood Pressure (BP) <140/90 - N/A - N/A 72.71 N/A
ACO #25 Tobacco Non Use - N/A - N/A 78.64 N/A
ACO #26 Aspirin Use - N/A - N/A 91.72 N/A
ACO #27 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) - - - - 13.87 20.32
ACO #28 Percent of beneficiaries with hypertension whose BP <140/90 - - - - 74.65 67.96
ACO #29 Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl - - - - N/A N/A
ACO #30 Percent of beneficiaries with IVD who use Aspirin or other antithrombotic - - - - 86.95 80.84
ACO #31 Beta-Blocker Therapy for LVSD - - - - 82.05 84.32
ACO #32 Drug Therapy for Lowering LDL Cholesterol - N/A - N/A N/A N/A
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD - N/A - N/A 77.1 N/A

CAHPS= Consumer Assessment of Healthcare Providers and Systems, PQI= Prevention Quality Indicator, LVSD= left ventrical systolic dysfunction, ACE= angiotensin-converting enzyme, ARB= angiotensin receptor blocker, CAD= coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A.

For more information on how to interpret scores on the above quality performance measures, see https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf

Links

www.cms.gov/Medicare/Shared Savings Program

Greater Baltimore Medical Center

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227. TTY users should call 1-877-486-2048.